Android app on Google Play

BofA/Merrill Lynch Downgrades Biogen (BIIB) to Neutral

January 15, 2013 6:49 AM EST Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $290.06 +1.60%

Rating Summary:
    20 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 32 | Down: 10 | New: 33
Trade BIIB Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Biogen (NASDAQ: BIIB) from Buy to Neutral.

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $143.88 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment